Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Eosinophilic Esophagitis (EoE) in Children as Young as 1 Year Old
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| Regeneron (NASDAQ: REGN) | Delayed: 819.09 +13.42 (1.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $805.67 | 52 Week High | $592.36 | |||
| Open | $809.01 | 52 Week Low | $325.35 | |||
| Day High | $825.52 | P/E | 214.98 | |||
| Day Low | $800.00 | EPS | $3.81 | |||
| Volume | 852,491 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 819.09 +13.42 (1.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $805.67 | 52 Week High | $592.36 | |||
| Open | $809.01 | 52 Week Low | $325.35 | |||
| Day High | $825.52 | P/E | 214.98 | |||
| Day Low | $800.00 | EPS | $3.81 | |||
| Volume | 852,491 | |||||
